Pharm
Eravacycline
search
Eravacycline
, Xerava
See Also
Tetracyclines
Indications
NOT indicated in complicated
Urinary Tract Infection
s
Intraabdominal infections
Bacteroides
species
Citrobacter
freundii
Clostridium perfringens
Enterobacter
cloacae
Enterococcus
faecalis
Enterococcus
faecium
Escherichia coli
Klebsiella
oxytoca
Klebsiella
Pneumonia
e
Parabacteroides distasonis
Staphylococcus aureus
Streptococcus
anginosus
Contraindications
Pregnancy and Children <8 years old
Permanent
Tooth Discoloration
Enamel Hypoplasia
Inhibited bone growth
Mechanism
See
Tetracyclines
Tetracycline
Class drug
Fluorocycline
Antibiotic
Dosing
Adult
Eravacycline 1 mg/kg every 12 hours
Adjustments
Strong
Cytochrome P-450 3A3/4 Isoenzyme
Inducers (see below)
Severe
Liver
Disease
Start with 1 mg/kg every 12 hours on day 1, then 1 mg/kg every 24 hours
Drug Interactions
Strong
Cytochrome P-450 3A3/4 Isoenzyme
Inducers (e.g.
Rifampin
)
Decreased serum levels of Eravacycline
Increase dose of Eravacycline to 1.5 mg/kg every 12 hours
Adverse Effects
Metabolic
Azotemia
(including increased BUN)
Metabolic Acidosis
Hyperphosphatemia
Tetracycline
class effects
Hepatotoxicity
Pancreatitis
Photosensitivity
Pseudotumor Cerebri
Clostridium difficile
Miscellaneous Reactions (<10%)
Infusion-Site Reaction
Nausea
Vomiting
Diarrhea
Hypotension
Safety
Pregnancy Category X
Unknown safety in
Lactation
Resources
Eravacycline Injection Powder for Solution (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a4b188d4-f467-470c-ad7b-25ffbdd8862a
References
LoVecchio (2019) Crit Dec Emerg Med 33(5): 32
Sutcliffe (2013) Antimicrob Agents Chemother 57(11): 5548-555 +PMID: 23979750 [PubMed]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3811277/
Type your search phrase here